Lynk Pharmaceuticals Completes Phase III AS Trial Enrollment
HANGZHOU, China, SHANGHAI & BOSTON — July 14, 2026 Lynk Pharmaceuticals Co., Ltd. has announced the successful completion of...
Clinical Trials for New Therapy
Akeso Opens U.S. Phase II Trial for PD-1/CTLA-4 Bispecific
HONG KONG, July 14, 2026 Akeso, Inc. has announced the launch of a Phase II clinical trial in the...
HitGen Partner BioAge Launches Phase II Trial for BGE-102
CHENGDU, China, July 14, 2026 HitGen Inc. has announced that its partner BioAge Labs has dosed the first participant...
Atrium Therapeutics Launches Phase 1/2 Trial for ATR 1072
SAN DIEGO, Calif., July 14, 2026 Atrium Therapeutics has achieved an important regulatory milestone after the U.S. Food and...
Cardiol Therapeutics Publishes Recurrent Pericarditis Phase II Data
TORONTO, Ontario, July 14, 2026 Cardiol Therapeutics Inc. has announced the publication of its Phase II MAvERIC clinical trial...
Leads Biolabs Secures Six ESMO 2026 Research Presentations
NANJING, China, July 13, 2026 Leads Biolabs has strengthened its position in global cancer immunotherapy after announcing that six...
Alzheimer’s Association Launches PROTECT-Cog Prevention Trial
LONDON, United Kingdom, July 13, 2026 The Alzheimer’s Association has announced the launch of the PROTECT-Cog Study (Prevention of...
Aethlon Medical Reports Encouraging Hemopurifier Trial Results
SAN DIEGO, California, July 13, 2026 Aethlon Medical, Inc. has announced encouraging interim findings from the second patient cohort...
Keenova Publishes New Real-World Acthar Gel Autoimmune Data
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
Q32 Bio Reports Positive Phase 2a Alopecia Trial Results
WALTHAM, Mass., July 13, 2026 Q32 Bio has announced positive 36-week topline results from Part B of the Phase...